Incorporating Post-Cessation Weight-Control Coaching into Smoking Cessation Therapy to Reduce Type 2 Diabetes Risk

Post-cessation weight gain (PCWG) facilitates short-term type 2 diabetes (T2D) risk in prediabetic smokers in the absence of complementary measures. In this shared decision-making-based non-randomized controlled trial, prediabetic smokers joined the Fight Tobacco and Stay Fit (FIT2) program or recei...

Full description

Bibliographic Details
Main Authors: Chien-Hsieh Chiang, Yi-Han Sheu, Fei-Ran Guo, Wan-Wan Lin, Guan-Ru Chen, Kuo-Chin Huang
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/10/3360
_version_ 1797513591301079040
author Chien-Hsieh Chiang
Yi-Han Sheu
Fei-Ran Guo
Wan-Wan Lin
Guan-Ru Chen
Kuo-Chin Huang
author_facet Chien-Hsieh Chiang
Yi-Han Sheu
Fei-Ran Guo
Wan-Wan Lin
Guan-Ru Chen
Kuo-Chin Huang
author_sort Chien-Hsieh Chiang
collection DOAJ
description Post-cessation weight gain (PCWG) facilitates short-term type 2 diabetes (T2D) risk in prediabetic smokers in the absence of complementary measures. In this shared decision-making-based non-randomized controlled trial, prediabetic smokers joined the Fight Tobacco and Stay Fit (FIT2) program or received usual care. The 16-week FIT2 program combined smoking cessation therapy with individualized coaching in diet and physical activity strategies for PCWG restriction (NCT01926041 at ClinicalTrials.gov). During a mean follow-up period of 1316 days, 217 participants (36.8%) developed T2D, and 68 (11.5%) regressed to normoglycemia. In the intention-to-treat analysis (<i>n</i> = 589), the FIT2 program was associated with a reduced T2D risk (HR, 0.58; 95% CI, 0.40–0.84) and a higher probability of regression to normoglycemia (HR, 1.91; 95% CI, 1.04–3.53) compared with usual care. The post-program quitters were at lower T2D risk (HR, 0.63; 95% CI, 0.44–0.92) and were more likely to regress to normoglycemia (HR, 1.83; 95% CI, 1.01–3.30) compared with the controls in the time-varying analysis (<i>n</i> = 532). We demonstrated that the FIT2 program was negatively associated with long-term T2D risk and positively associated with the probability of regression to normoglycemia compared with usual care. To prevent T2D development, we recommend simultaneously promoting smoking abstinence and lifestyle coaching for PCWG restriction.
first_indexed 2024-03-10T06:19:42Z
format Article
id doaj.art-f9bac6859a2c48fd9b946e4f4b891827
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T06:19:42Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-f9bac6859a2c48fd9b946e4f4b8918272023-11-22T19:27:20ZengMDPI AGNutrients2072-66432021-09-011310336010.3390/nu13103360Incorporating Post-Cessation Weight-Control Coaching into Smoking Cessation Therapy to Reduce Type 2 Diabetes RiskChien-Hsieh Chiang0Yi-Han Sheu1Fei-Ran Guo2Wan-Wan Lin3Guan-Ru Chen4Kuo-Chin Huang5Department of Family Medicine, National Taiwan University Hospital & College of Medicine, Taipei 100, TaiwanDepartment of Psychiatry, Harvard Medical School, Boston, MA 02115, USADepartment of Family Medicine, National Taiwan University Hospital & College of Medicine, Taipei 100, TaiwanGraduate Institute of Pharmacology, National Taiwan University College of Medicine, Taipei 100, TaiwanDepartment of Community and Family Medicine, National Taiwan University Hospital Yunlin Branch, Douliu 640, TaiwanDepartment of Family Medicine, National Taiwan University Hospital & College of Medicine, Taipei 100, TaiwanPost-cessation weight gain (PCWG) facilitates short-term type 2 diabetes (T2D) risk in prediabetic smokers in the absence of complementary measures. In this shared decision-making-based non-randomized controlled trial, prediabetic smokers joined the Fight Tobacco and Stay Fit (FIT2) program or received usual care. The 16-week FIT2 program combined smoking cessation therapy with individualized coaching in diet and physical activity strategies for PCWG restriction (NCT01926041 at ClinicalTrials.gov). During a mean follow-up period of 1316 days, 217 participants (36.8%) developed T2D, and 68 (11.5%) regressed to normoglycemia. In the intention-to-treat analysis (<i>n</i> = 589), the FIT2 program was associated with a reduced T2D risk (HR, 0.58; 95% CI, 0.40–0.84) and a higher probability of regression to normoglycemia (HR, 1.91; 95% CI, 1.04–3.53) compared with usual care. The post-program quitters were at lower T2D risk (HR, 0.63; 95% CI, 0.44–0.92) and were more likely to regress to normoglycemia (HR, 1.83; 95% CI, 1.01–3.30) compared with the controls in the time-varying analysis (<i>n</i> = 532). We demonstrated that the FIT2 program was negatively associated with long-term T2D risk and positively associated with the probability of regression to normoglycemia compared with usual care. To prevent T2D development, we recommend simultaneously promoting smoking abstinence and lifestyle coaching for PCWG restriction.https://www.mdpi.com/2072-6643/13/10/3360prediabetesprimary caresmoking cessationtype 2 diabetes mellitusobesity
spellingShingle Chien-Hsieh Chiang
Yi-Han Sheu
Fei-Ran Guo
Wan-Wan Lin
Guan-Ru Chen
Kuo-Chin Huang
Incorporating Post-Cessation Weight-Control Coaching into Smoking Cessation Therapy to Reduce Type 2 Diabetes Risk
Nutrients
prediabetes
primary care
smoking cessation
type 2 diabetes mellitus
obesity
title Incorporating Post-Cessation Weight-Control Coaching into Smoking Cessation Therapy to Reduce Type 2 Diabetes Risk
title_full Incorporating Post-Cessation Weight-Control Coaching into Smoking Cessation Therapy to Reduce Type 2 Diabetes Risk
title_fullStr Incorporating Post-Cessation Weight-Control Coaching into Smoking Cessation Therapy to Reduce Type 2 Diabetes Risk
title_full_unstemmed Incorporating Post-Cessation Weight-Control Coaching into Smoking Cessation Therapy to Reduce Type 2 Diabetes Risk
title_short Incorporating Post-Cessation Weight-Control Coaching into Smoking Cessation Therapy to Reduce Type 2 Diabetes Risk
title_sort incorporating post cessation weight control coaching into smoking cessation therapy to reduce type 2 diabetes risk
topic prediabetes
primary care
smoking cessation
type 2 diabetes mellitus
obesity
url https://www.mdpi.com/2072-6643/13/10/3360
work_keys_str_mv AT chienhsiehchiang incorporatingpostcessationweightcontrolcoachingintosmokingcessationtherapytoreducetype2diabetesrisk
AT yihansheu incorporatingpostcessationweightcontrolcoachingintosmokingcessationtherapytoreducetype2diabetesrisk
AT feiranguo incorporatingpostcessationweightcontrolcoachingintosmokingcessationtherapytoreducetype2diabetesrisk
AT wanwanlin incorporatingpostcessationweightcontrolcoachingintosmokingcessationtherapytoreducetype2diabetesrisk
AT guanruchen incorporatingpostcessationweightcontrolcoachingintosmokingcessationtherapytoreducetype2diabetesrisk
AT kuochinhuang incorporatingpostcessationweightcontrolcoachingintosmokingcessationtherapytoreducetype2diabetesrisk